Non-invasive Assessment of RECTUM (POUCH) by US (RECT-US) in a Cohort of IBD Patients

San Donato Group (GSD)

Status: Enrolling

Conditions: Ulcerative Colitis; Crohn's Disease

Study type: Observational

Funder types: Other

Identifiers

NCT06407674

RECT-US

Details and patient eligibility

About

At enrollment, after informed consent form will be discussed and signed, subjects will undergo complete disease assessment.

In this study, 150 adult subjects with IBD will be enrolled at the Gastroenterology Department of the San Raffaele Hospital (50 patients with Crohn's disease, 50 with Ulcerative colitis not undergoing proctocolectomy, and 50 with Ulcerative colitis undergoing proctocolectomy with ileal pouch-anal anastomosis).

All the patients will perform routine investigations with Ileocolonoscopy (IC), according to the current standard of care indications and ECCO guidelines, and they will be assessed by both Intestinal Ultrasound (IUS) and Trans-perineal ultrasound (TPUS). Blood and stool samples will be obtained for fecal calprotectin (FC) and C-reactive protein (CRP) measurements, respectively, as normal clinical practice.

All the procedures of this study are performed routinely in clinical practice. All the procedures are performed in a single day-visit for the patient.

Enrollment: 150 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed diagnosis of IBD for at least 3 months, in particular 50 with Crohn&;s disease (CD), 50 with ulcerative colitis (UC) not undergoing proctocolectomy, 50 with ulcerative colitis (UC) undergoing proctocolectomy with ileal pouch-anal anastomosis
• Performing ileocolonoscopy, according to current standards of care and ECCO guidelines, will be assessed by both IUS and TPUS. Procedures performed routinely in clinical practice
• Ability to understand and comply with the study procedure and sign an informed consent form

Exclusion criteria

• Pregnancy;
• Concomitant intestinal infection (e.g. Clostridium difficile);
• Cirrhosis or intra-abdominal ascites.
• Subjects not able to comply with any study procedure;
• Subjects not able to understand and give informed consent form;
• Subjects with any contraindication to any study procedure.

Trial design

150 participants in 2 patient groups

ulcerative colitis

crohn's disease